Related by context. Frequent words. (Click for all words.) 70 sustained virologic response 67 peginterferon 66 HCV genotype 1 65 nonresponders 63 pegylated interferon 63 evaluable patients 63 plus ribavirin 63 peginterferon alfa 2a 62 evaluable 62 chronic HCV infection 60 chronic HCV 60 RECIST criteria 60 adefovir 59 adalimumab 59 HCV RNA 59 lamivudine 59 tumor shrinkage 58 undetectable viral load 58 infliximab 58 metastatic renal cell carcinoma 58 raltegravir 57 dasatinib 57 ribavirin 57 vicriviroc 57 HCV infection 57 Phase 2a trial 57 seroconversion 57 boceprevir 57 mg BID 57 free survival PFS 57 linezolid 57 nilotinib 57 HCV infected 56 IU mL 56 imatinib 56 copies mL 56 entecavir 56 median PFS 56 refractory multiple myeloma 56 mg dose 56 azacitidine 56 mcg kg 56 febrile neutropenia 56 chronic angina 56 ISENTRESS 56 copies ml 55 Median survival 55 discontinuations due 55 abatacept 55 dose limiting toxicities 55 relapsing remitting MS 55 relapsing remitting 55 temsirolimus 55 viral suppression 55 bortezomib 55 anti TNF 55 etanercept 55 mitoxantrone 55 topotecan 55 bevirimat 55 TMC# [001] 55 DMARDs 55 FOLFOX 55 Ribavirin 55 lupus nephritis 55 telaprevir 55 interferon 55 placebo controlled trials 55 vinorelbine 55 telbivudine 55 hypercalcemia 55 events AEs 54 laboratory abnormalities 54 TORISEL 54 lacosamide 54 monotherapy 54 tumor regression 54 bone metastasis 54 chronic hepatitis C 54 elagolix 54 pharmacodynamic 54 IDX# 54 viral loads 54 PXD# 54 ACR# [002] 54 PEGINTRON 54 castration resistant prostate cancer 54 chronic lymphocytic leukemia CLL 54 bosentan 54 Secondary endpoints 54 ofatumumab 54 ceftriaxone 54 HbA1c levels 54 placebo 54 azathioprine 54 myelodysplastic syndromes MDS 54 pregabalin 54 JANUVIA 54 limiting toxicity 53 placebo p = 53 hematologic